Article Sidebar

pdf
Date Published: 24/11/2023
Abstract Views: 321
Views pdf: 141
DOI: https://doi.org/10.51298/vmj.v532i1.7301
Issue
Vol. 532 No. 1 (2023)
Section
Các bài báo
How to Cite
Phan, T. K. A., & Hoàng, M. T. (2023). THE SITUATION OF FATTY LIVER AND RELATED FACTORS IN SY VINA JOINT STOCK COMPANY EMPLOYEES IN 2022 - 2023. Vietnam Medical Journal, 532(1). https://doi.org/10.51298/vmj.v532i1.7301

THE SITUATION OF FATTY LIVER AND RELATED FACTORS IN SY VINA JOINT STOCK COMPANY EMPLOYEES IN 2022 - 2023

Thị Kim Anh Phan1, Minh Tú Hoàng2,
1 Nhon Trach District Medical Cente
2 Can Tho University of Medicine and Pharmacy

Main Article Content

Abstract

Background: Fatty liver disease (FLD) is a common liver disorder that is increasing in prevalence and has serious consequences. Objective: To determine the prevalence of fatty liver disease and investigate related factors among employees of SY VINA Limited Liability Textile Company (SY VINA Company). Material and methods: A cross-sectional descriptive study was conducted on 370 employees of SY VINA Company in Dong Nai province. The employees were interviewed using a set of questions and underwent general abdominal ultrasound from September 2022 to June 2023. Results: The prevalence of fatty liver disease among company employees was 43.24%, with Grade I fatty liver disease being the most common, accounting for 56.88% (91/160). Overweight and obese employees had a higher prevalence of fatty liver disease, with corresponding rates of 31.88% and 31.25%. There was an association between fatty liver disease and age group, BMI group, central obesity status, and the level of fat consumption by employees. Conclusion: The prevalence of fatty liver disease is high among employees who are overweight, obese, and have a high fat intake. Appropriate health education and communication measures are needed to reduce the prevalence of fatty liver disease.

Article Details

Keywords

: fatty liver, related factors, abdominal ultrasound.

References

1. Nguyễn Thế Dũng, Đào Đức Tiến, Trần Hà Hiền và cs (2021), "Đặc điểm bệnh gan nhiễm mỡ không do rượu ở bệnh nhân rối loạn lipid máu tại Bệnh viện Quân y 175", Tạp chí Y học thực hành 175, 25, tr. 5-12.
2. Nguyễn Thị Sinh, Trịnh Xuân Đàn, Nguyễn Văn Quỳnh và cs (2021), "Mối tương quan của sự tích tụ mỡ bụng trên hình ảnh siêu âm với chỉ số nhân trắc ở bệnh nhân gan nhiễm mỡ", Tạp chí Y học Việt Nam, 501(1), tr. 18-21.
3. Hoàng Trọng Thảng, Huỳnh Thị Bích Thủy (2011), "Nghiên cứu hoạt động transaminase, rối loạn glucose máu, lipid máu ở bệnh nhân gan nhiễm mỡ không do rượu", Tạp chí Gan mật Việt Nam, 16+17, tr. 41-50.
4. Phạm Cao Trí, Trần Ngọc Dung (2021), "Tình hình gan nhiễm mỡ và một số yếu tố liên quan ở cán bộ do ban bảo vệ sức khỏe Tỉnh ủy Sóc Trăng quản lý năm 2020 - 2021", Tạp chí Y Dược học Cần Thơ, 39, tr. 166-172.
5. Inciardi R.M., Mantovani A., and Targher G. (2023), "Non-Alcoholic Fatty Liver Disease as an Emerging Risk Factor for Heart Failure", Current Heart Failure Reports, 20(4), pp. 308-319.
6. Quek J., Chan K.E., Wong Z.Y. et al (2023), "Global prevalence of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in the overweight and obese population: a systematic review and meta-analysis", Lancet Gastroenterol Hepatol, 8(1), pp. 20-30.
7. Teng M.L.P., Ng C.H., Huang D.Q. et al (2023), "Global incidence and prevalence of nonalcoholic fatty liver disease", Clin Mol Hepatol, 29(Suppl), pp. S32-S42.
8. Ziolkowska S., Kosmalski M., Kolodziej L. et al (2023), "Single-Nucleotide Polymorphisms in Base-Excision Repair-Related Genes Involved in the Risk of an Occurrence of Non-Alcoholic Fatty Liver Disease", Int J Mol Sci, 24(14).